{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-004793","form_type":"8-K","ticker":"GCTK","cik":"0001506983","company_name":"Glucotrack, Inc.","filed_at":"2025-02-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.832704+00:00","generated_at":"2026-05-27T03:25:25.655526+00:00","sec_items":["5.03","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Glucotrack completes 1:20 reverse stock split; first human CBGM study successful with no serious adverse events","bullets":["Effective Feb 3, 2025, every 20 pre-split shares combined into 1 share; outstanding shares reduced from ~155.5M to ~7.8M.","First in-human CBGM study met primary endpoint: no procedure- or device-related serious adverse events from implant through 7 days post-removal.","Six participants with diabetes mellitus; CBGM sensor lead placed intravascularly in subclavian vein for 4-day in-hospital monitoring.","Study confirmed CBGM sensor lead function; system accuracy consistent with prior animal studies; next step is long-term clinical trials.","Ticker GCTK unchanged; new CUSIP 45824Q705; shares trade on split-adjusted basis from Feb 4, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-004793","json":"https://secwatch.observer/filing/0001493152-25-004793.json","markdown":"https://secwatch.observer/filing/0001493152-25-004793.md","text":"https://secwatch.observer/filing/0001493152-25-004793.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506983/000149315225004793/0001493152-25-004793-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506983/000149315225004793/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T03:25:25.655526+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}